All Press Releases for January 23, 2023

LogicInk gets listed on THE OCMX™

The OCMX™ is pleased to announce the listing of LogicInk to its online portal which offers financial networks the ability to learn more about this exciting opportunity.

    SAN FRANCISCO, CA, January 23, 2023 /24-7PressRelease/ -- LogicInk gets listed on THE OCMX™

LogicInk is a lifestyle sensor company, developing bio-chemical Signals that can be worn or applied daily. From the screening of Covid-infected presymptomatic people, to the early detection of genetic traits that may be harmful later in life, we focus on increasing your knowledge to support every facet of your daily wellness effort.

LogicInk's focus is in developing a saliva-based, at-home molecular test, called Genetic Signal. The signal is instrument-free, battery-free and has PCR sensitivity, unlocking hundreds of markets and applications where PCR testing is done today but without the need for centralized labs and/or bulky, expensive, cumbersome instrumentation.

In essence, we are democratizing ultra-sensitive molecular testing for every-day use, empowering people with information to live a longer and healthier life.

The OCMX™ is pleased to announce the listing of LogicInk to its online portal which offers financial networks the ability to learn more about this exciting opportunity.

The OCMX™ has spent considerable time completing its due diligence on LogicInk and concluded that there is indeed a tremendous potential for this company.

The OCMX™ noted that LogicInk exhibits the main components of any solid opportunity, namely a solid management team, a great track record, and several key competitive advantages.

Market opportunity
Ultimately, LogicInk Genetic Signal represents a health + wellness product opportunity spanning multibillion dollar markets under one platform.

Experienced team with track record of success
We have been able to attract some of the most renown world scientists, some of whom are arguably among the top 5 world experts in DNA nanotech to execute on a shared vision of a health + wellness biosensor platform.

Established investor backing
We've attracted early-stage funding from organizations such as Thiel Foundation (Peter Thiel), Village Global (LPs Jeff Bezos, Mark Zuckerberg, and others), Metaplanet (Skype CoFounder Jaan Tallin), some of whom are already repeat investors or are planning to be so as we keep showing progress.

Once-in-a-lifetime opportunity
LogicInk's progress is being tracked by a few multi-billion companies, and by high profile personalities who recognize the power of the Genetic Signal platform. We understand that once we fully complete the signal's biochemistry– where we are in the last mile of achieving – additional resources will be poured in by our largest investors and partners under significantly different terms.

Our beachhead market is the screening of Covid and other respiratory diseases. People are most contagious as early as 2 days before symptoms appear, yet, existing tests are not able to accurately detect presymptomatic carriers or are too expensive or impractical to be used frequently. Yet today, Covid remains the third leading cause of deaths in the US.

Beyond respiratory diseases, we are working on establishing partnerships where our Genetic Signal platform can be programmed to screen for nucleic acids sequences associated with other conditions of interest, specifically, we are focusing on concussion screening as a second market and have received already the attention of the NFL.

• Secured $6.1 million from investors including The Thiel Foundation (Peter Thiel), Village Global (Jeff Bezos, Bill Gates, Mark Zuckerberg), Metaplanet (Skype cofounder, Jaan Tallin)
• Secured $1 million from Fortune 50/100/200 and NIH SBIR Phase I grant to develop a range of functional prototypes as part of a product-market fit exploration
• Fully developed a Suncare Signal product (pre-pandemic roadmap) with the capacity to scale its manufacturing to tens of millions of units per month
• Brought together some of the most renowned scientists in the world in DNA nanotech, including Hendrik Dietz, Paul Rothemund, Chris Thachuk, and Shawn Douglas
• FastCompany Life Changing Ideas Finalist
• Recipient of NIH SBIR Phase I grant
• Featured in multiple shows including Disney+'s The World According to Jeff Goldblum, T-Pain School of Business
• Selected to be part of multiple accelerator programs, including most recently FitTech Club, "a business community of the age of health"

Carlos Olguin, MSc, Founder and CEO
Carlos has established an exceptional multidisciplinary team that is pioneering new chemical and biological materials and technologies and their potential applications for biosensing. Carlos has considerable expertise in programmable matter applications developed in part after founding and leading the Bionano Research group at Autodesk –later Autodesk Life Sciences.

Hendrik Dietz, PhD, Co-Founder and acting Chief Scientist
Hendrik is a physicist by training and ranks among the world's leading researchers in DNA nanotechnology. Dietz routinely publishes in high-ranking journals such as Nature and Science, has multiple patents, and is an entrepreneur seeking to translate academic insights into commercial products.

Paul Wilhelm Karl Rothemund, PhD, Advisor and DNA Nanotech Consultant
Paul is a research professor at Caltech invented the field of DNA origami. He shared both categories of the 2006 Feynman Prize in Nanotechnology with Erik Winfree for their work in creating DNA nanotubes, algorithmic molecular self-assembly of DNA tile structures, and their theoretical work on DNA computing. Rothemund is also a 2007 recipient of the MacArthur Fellowship.

Steven Wrobel, Co-Founder and Principal Scientist
Steven has a degree in Chemistry from UC Berkeley. Steve has been instrumental in the design, implementation, and calibration of LogicInk Suncare Signals. His work at LogicInk also includes co-inventing and implementing a POC of a highly unique pollution sensor (PM2.5) that precludes electronics and can be used in a variety of scenarios.

Don Voss, MBA, Board Advisor and Business Development
Don has a Masters in Business Administration from Pepperdine University. He has extensive experience in Finance, Operations, Global Sales, and Partnership Marketing with Kimberly Clark and The Coca-Cola Company. Don is responsible for the Sales and route to market strategic execution.

E Roon Kang, MFA, Design Lead
E Roon holds a Master of Fine Arts from Yale. He is an Assistant Professor at Parsons School of Design, a Senior TED Fellow and was previously a research fellow at SENSEable City Lab at MIT. He is an award-winning designer and educator with a history of designing brand, editorial, and product experience partnering with various organizations including MIT Media Lab, UCLA Architecture, Google Fonts, LACMA Art + Technology Lab, and Venice Architecture Biennale.

The OCMX™, established in 2009, is a next generation investor relations and marketing outreach firm. Through our online OCMX portal, we connect companies with financial networks, generating interest and awareness for their opportunity.

Contact Us
TD Canada Trust Tower
161 Bay Street, 45th Floor
Toronto, Ontario, M5J 2S1
Tel: 1-866-209-6862
Email: [email protected]

# # #

Contact Information

David Clarke
Toronto, Ontario
Voice: 866-206-6862
E-Mail: Email Us Here